Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Adlai Nortye Biopharma Co., Ltd.
Scientific Title
The BURAN Study of Buparlisib (AN2025) In Combination With Paclitaxel Compared to Paclitaxel Alone, in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma